Stavra Xanthakos (@drstavra) 's Twitter Profile
Stavra Xanthakos

@drstavra

PedsGI doctor. Director Steatohepatitis Center. Obesity and Bariatric Medicine Specialist. Professor of Pediatrics @CincyChildrens @UCincyMedicine Views my own

ID: 1347603555667087361

calendar_today08-01-2021 18:03:09

210 Tweet

208 Followers

500 Following

Stavra Xanthakos (@drstavra) 's Twitter Profile Photo

At ##DDW2025, Dr. Rohit Kohli gave an outstanding overview of seminal new studies in pediatric liver disease Rohit Kohli, MBBS, MSCI, FAASLD, NASPGHAN-F These papers will impact clinical practice! #AASLD #NASPGHAN

At ##DDW2025,  Dr. Rohit Kohli gave an outstanding overview of seminal new studies in pediatric liver disease <a href="/liver4kids/">Rohit Kohli, MBBS, MSCI, FAASLD, NASPGHAN-F</a> These papers will impact clinical practice!  #AASLD #NASPGHAN
NASPGHAN (@naspghan) 's Twitter Profile Photo

The NASPGHAN Foundation Mid-Career Award is designated for NASPGHAN members at the mid-career level who are pursuing research in pediatric gastroenterology, hepatology, and nutrition. Learn more about grant opportunities: naspghan.org/research/naspg…

Stavra Xanthakos (@drstavra) 's Twitter Profile Photo

#PedsGI, #PedsLiver, and nature lovers🪻🚵‍♀️, come discover, relax and recharge at CincyKidsCME 47th annual #AspenPedsGIConference July 14-18th, 2025! Elevate your expertise in cutting-edge pediatric liver disease management and network with expert faculty and colleagues! Explore

#PedsGI, #PedsLiver, and nature lovers🪻🚵‍♀️, come discover, relax and recharge at <a href="/CincyKidsCME/">CincyKidsCME</a> 47th annual #AspenPedsGIConference July 14-18th, 2025!
Elevate your expertise in cutting-edge pediatric liver disease management and network with expert faculty and colleagues! Explore
Stavra Xanthakos (@drstavra) 's Twitter Profile Photo

Join our #AspenPedsGI faculty as we discuss all the latest in pediatric liver updates, including daily case-based discussions and new diagnostics/therapeutics! Submit your own clinical challenges for discussion👀👉cchmc.cloud-cme.com/course/courseo…

Join our #AspenPedsGI faculty as we discuss all the latest in pediatric liver updates, including daily case-based discussions and new diagnostics/therapeutics!  Submit your own clinical challenges for discussion👀👉cchmc.cloud-cme.com/course/courseo…
ASGE GI Endoscopy (@asgeendoscopy) 's Twitter Profile Photo

Only a few weeks left to submit your session proposal for #DDW2026! Don't miss your chance to lead, inspire and advance the field. Submit your proposal today! hubs.ly/Q03jY88M0 #DDW2026 #GIEndoscopy #Endoscopy #Gastroenterology

Stavra Xanthakos (@drstavra) 's Twitter Profile Photo

We are excited to announce a hands-on Point of Care Ultrasound (POCUS) satellite session is now open for registration during the upcoming #AspenPedsGI Conference in Snowmass, CO, July 14-18,2025. Sponsored by Aegle Medical and Mindray North America, this special add-on session will take

We are excited to announce a hands-on Point of Care Ultrasound (POCUS) satellite session is now open for registration during the upcoming #AspenPedsGI  Conference in Snowmass, CO, July 14-18,2025.  Sponsored by <a href="/AegleMedical/">Aegle Medical</a> and <a href="/Mindray_NA/">Mindray North America</a>, this special add-on session will take
JPGN (@jpgnonline) 's Twitter Profile Photo

Even with a gluten-free diet, kids with celiac disease can develop anemia, vitamin deficiencies, and liver or thyroid issues years later. 📊 Ongoing lab monitoring is key. 🔗 doi.org/10.1002/jpn3.7… #pediatrics #pedsgi #openaccess #celiacdisease

Even with a gluten-free diet, kids with celiac disease can develop anemia, vitamin deficiencies, and liver or thyroid issues years later.

📊 Ongoing lab monitoring is key.

🔗 doi.org/10.1002/jpn3.7…

#pediatrics #pedsgi #openaccess #celiacdisease
Stavra Xanthakos (@drstavra) 's Twitter Profile Photo

Have you registered for the 47th annual #AspenPedsGI Conference July 14-18th, 2025 in Snowmass, Colorado? ⏰EARLY registration rates end on July 1, 2025. Elevate your expertise in cutting-edge pediatric liver disease management and network with expert faculty and colleagues,

Have you registered for the 47th annual #AspenPedsGI Conference July 14-18th, 2025 in Snowmass, Colorado?  ⏰EARLY registration rates end on July 1, 2025. Elevate your expertise in cutting-edge pediatric liver disease management and network with expert faculty and colleagues,
Stavra Xanthakos (@drstavra) 's Twitter Profile Photo

Don’t miss the hands-on Point of Care Ultrasound satellite session during the #AspenPedsGIConference in Snowmass, CO, on July 16,2025! EARLY registration ends July 1, 2025. Lunch will be provided. Select POCUS add-on option during registration at cincinnatichildrens.org/AspenGI.

Don’t miss the hands-on Point of Care Ultrasound satellite session during the #AspenPedsGIConference in Snowmass, CO, on July 16,2025! EARLY registration ends July 1, 2025. Lunch will be provided. Select POCUS add-on option during registration at cincinnatichildrens.org/AspenGI.
NASPGHAN President (@naspghanprez) 's Twitter Profile Photo

Are you 2–7 years out of GI fellowship (June 2018–2023)? Apply now for NASPGHAN's Jr Career Development Conference! Boost your leadership, strategy, & professional skills. Travel, lodging, meals included. 50 spots only—apply by July 22, only 3 weeks away! tinyurl.com/2s47u6m2

Are you 2–7 years out of GI fellowship (June 2018–2023)? Apply now for <a href="/NASPGHAN/">NASPGHAN</a>'s Jr Career Development Conference! Boost your leadership, strategy, &amp; professional skills. Travel, lodging, meals included. 50 spots only—apply by July 22, only 3 weeks away! tinyurl.com/2s47u6m2
Jeff Schwimmer (@theliverpost) 's Twitter Profile Photo

📢 New in Journal of Clinical Investigation : We explore pediatric MASLD as a distinct, early-onset liver disease shaped by perinatal factors, genetics, and hepatic zonation. Sudha Biddinger Samar Ibrahim Opportunities for early intervention start in childhood. 🔗jci.org/articles/view/…

Ramon Bataller (@rabataller) 's Twitter Profile Photo

🚨 Big milestone in MASLD/MASH! We now have two FDA-approved drugs: 🔸 Resmetirom (oral, THR-β agonist) 🔹 Semaglutide (weekly SC, GLP-1 RA) I made this simple side-by-side comparison 👇

🚨 Big milestone in MASLD/MASH!
We now have two FDA-approved drugs:
🔸 Resmetirom (oral, THR-β agonist)
🔹 Semaglutide (weekly SC, GLP-1 RA)

I made this simple side-by-side comparison 👇
Stavra Xanthakos (@drstavra) 's Twitter Profile Photo

As use of GLP1 RA medicines increases, it wil be very important to monitor body composition and strategies to preserve and promote skeletal muscle mass